Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 14, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
Dry Eye SyndromeGlaucoma and Concomitant Dry Eye SyndromeOcular Hypertension and Concomitant Dry Eye SyndromeMultiple Long-term Topical Hypotensive Therapy
Interventions
DEVICE

Iridium A Gel

IRIDIUM® A gel is a sterile, preservative free ophthalmic gel, containing Carbopol, amino acids, Echinacea and Aloe extract. IRIDIUM® A gel is indicated for the protection of the eye surface particularly at night, even in the presence of changes in histological continuity and blepharitic conditions, including those of an iatrogenic nature, following the use of hypotonic eye drops and of the preservatives contained therein.

Trial Locations (3)

16132

RECRUITING

Policlinico San Martino, Genova

56124

RECRUITING

AOU Pisana Ospedale Cesanello, Pisa

00183

RECRUITING

IRCCS Fondazione G.B. Bietti, Roma

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY